SGStuart Mark Greenstein

Stuart Mark Greenstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stuart Mark Greenstein has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Jay A. Graham

    Department of Surgery Montefiore Medical Center Bronx New York USA

    3 shared publications
  • Attasit Chokechanachaisakul

    Albert Einstein College of Medicine, Bronx, NY, USA; Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Bronx, NY, USA

    2 shared publications
  • David P. Foley

    Department of Surgery, University of Wisconsin, Madison, WI

    2 shared publications
  • Enver Akalin

    Albert Einstein College of Medicine, Bronx, NY, USA; Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Bronx, NY, USA

    2 shared publications
  • Juan Rocca

    Montefiore Einstein Center for Transplantation, Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, NY, USA

    2 shared publications
  • Kayla Applebaum

    Albert Einstein College of Medicine, Bronx, NY, USA

    2 shared publications

Latest Publications

  • Open Access

    Successful Salvage of a Pancreas Allograft Following Duodenal and Partial Pancreatic Necrosis 21 Years After Simultaneous Pancreas-Kidney Transplantation: A Case Report

    by Marco Emilio Diaz-Cordova, Matthew Rega, Ryosuke Misawa, Abhay Dhand, Seigo Nishida, Stuart Mark Greenstein, Kenji Okumura

    Simultaneous pancreas-kidney transplantation is an established treatment for type 1 diabetes mellitus and renal dysfunction. However, pancreatic graft complications frequently require graft pancreatectomy. This report describes successful salvage of a functioning pancreas allograft despite extensive duodenal and partial pancreatic necrosis occurring 21 years after transplantation.A 68-year-old man with a simultaneous pancreas-kidney transplant performed 21 years earlier presented with acute right lower quadrant abdominal pain, nausea, and vomiting. Laboratory evaluation revealed leukocytosis and elevated serum creatinine. Computed tomography identified a dilated small-bowel loop adjacent to the pancreatic allograft with pneumatosis and free fluid. Emergency exploratory laparotomy revealed necrosis of the graft duodenum and a severely dilated jejunal segment, which was separated from the graft. The abdomen was temporarily closed to allow bowel demarcation. On re-exploration, most of the graft duodenum and a portion of the pancreatic head were necrotic and were debrided, leaving a viable pancreatic graft remnant. External drainage of pancreatic secretions was established, and bowel continuity was restored. At discharge, the C-peptide level was 1.24 ng/mL, and insulin requirements steadily decreased. The patient achieved insulin independence within four weeks. Five months later, a pancreatic fistula developed and was successfully managed with Roux-en-Y pancreaticojejunostomy at seven months. The patient remained insulin-free for 14 months.This case illustrates that pancreas allograft salvage is feasible despite extensive graft duodenal and partial pancreatic necrosis when graft perfusion and endocrine function are preserved. Staged operative management can maintain graft function and avoid graft pancreatectomy.

  • Open Access

    331.6: Impact of Left Ventricular Ejection Fraction and Previous Cardiac Revascularization on Patient and Graft Survival in Kidney Transplant Receipts

    by Dominic Amara, Miguel Nunez, Justin Parekh, David Foley, Stuart Greenstein, Ryutaro Hirose

  • COVID-19 in Kidney Transplant Recipient and Waitlist Patients

    by Yuchen Dong, Anant Dhingra, Stephanie B. Shamir, Yorg A. Azzi, Kenny Ye, Stuart M. Greenstein, Linda B. Haramati

    Purpose: To evaluate the chest radiographic severity score (CXR-SS) for coronavirus disease 2019 (COVID-19) patients who are kidney transplant recipients compared with patients on the waitlist. Study Design and Methods: This retrospective cohort includes 78 kidney transplant recipients (50 men, mean age 59.9±11.9 y) and 59 kidney transplant waitlist patients (33 men, mean age 58.8±10.8 y) diagnosed with COVID-19 between March 15 and May 30, 2020 with reverse transcriptase-polymerase chain reaction. Patient chest radiographs were divided into 6 zones and examined for consolidation. Primary outcome was mortality. Secondary outcomes included hospital admission, intensive care unit (ICU) admission, and intubation. Predictors of our primary and secondary outcomes were identified by bivariate analysis and multivariate regression analysis. Results: No significant difference was found in CXR-SS between 2 groups (P=0.087). Transplant recipients had significantly higher rates of hospitalization (odds ratio, 6.8; 95% confidence interval: 1.7, 39.3; PP=0.002), intubation (odds ratio, 11; 95% CI: 2.4-96.9; P=0.001), and mortality (odds ratio, 17; 95% CI: 3.9-153.1; PP=0.0314). Conclusion: The CXR-SS was not predictive of mortality, ICU admission or intubation in our population. Kidney transplant patients with COVID-19 had near universal hospital admission, more than one-third mortality and about a quarter were intubated and admitted to the ICU—all significantly worse outcomes than for patients on the transplant waitlist.


  • Open Access

    Predictors of Mid-Term Glomerular Filtration Rate after Deceased Donor Renal Transplantation: Kidney Donor Profile Index as a Predictor of Mid-Term GFR

    by Oya M. Andacoglu, Jack Liu, Abigail L. Brooks, Amit Blumfield, Mehul Trivedi, Shoshana Lehman, Michael K. Parides, Enver Akalin, Jay A. Graham, Juan P. Rocca, et al.

    Glomerular filtration rate (GFR) is an excellent indicator of renal function; however, it is rarely evaluated as an endpoint. We investigated donor and recipient factors for associations that might be predictive of mid-term GFR after renal transplantation. We performed a retrospective review of 828 deceased donor renal transplantations performed at Montefiore Medical Center between the years 2009-2015. Donor characteristics included KDPI, [low (80%)], age, graft types [extended criteria (ECD), cardiac death (DCD), standard criteria (SCD)], CDC high risk, HCV status and cold ischemic time (CIT). Recipient factors included age at transplant, induction agent, BK status, CMV status, acute and chronic rejection, cPRA and DSA status. Primary outcome is 3-year GFR calculated via the MDRD equation. In univariate analysis, donor age, KDPI, ECD, and chronic rejection were significantly associated with changes in 3-year GFR (p<0.001). In the multivariable regression analysis, donor age, KDPI, and chronic rejection remained associated with changes in 3-year GFR (p0.05). We conclude that donor age, KDPI, and chronic rejection are independently associated with 3-year GFR while acute rejection, DCD, HCV status, CIT, BK and CMV viremia, PRA, existing or de novo DSA were not. Based on these findings, current scoring systems may need refinement to address the prognosis of mid-term GFR.

  • COVID-19 and the Response of Transplant Centers: the Global Response with an Emphasis on the Kidney Recipient

    by Yorg Azzi, Abigail Brooks, Hillary Yaffe, Stuart Greenstein

    Purpose of the Review In response to the COVID-19 pandemic, vulnerable populations, such as transplant patients, were at greater risk than the regular population. In order to protect these populations, transplant centers enacted new guidelines. We approach this review by looking at how different transplant regions responded to COVID-19 and analyze the unifying themes that have proven invaluable in the subsequent waves. Recent Findings We noticed that most elective surgeries including living donor transplant operations were suspended in most countries. The response to deceased donor transplants varied between countries: in some deceased donor transplants continued with modified donor and recipient criteria, while in other countries this surgery was suspended. There was a general trend of decreasing or holding antimetabolites, treating the virus with hydroxychloroquine and/or azithromycin, and converting outpatient clinics to virtual clinics. Summary We learned how to carefully select donors and recipients, tailor immunosuppressant regiments, and implement telemedicine. The kidney recipient population can be effectively managed in times of crisis with appropriate accommodations and measures. This review can be a model for the transplant community for future pandemics.


  • Open Access

    Understanding the Impact of Pneumonia and Other Complications in Elderly Liver Transplant Recipients: An Analysis of NSQIP Transplant

    by Gabriel T. Schnickel, Stuart Greenstein, Jennifer A. Berumen, Nahel Elias, Debra L Sudan, Kendra D. Conzen, Kristin L. Mekeel, David P. Foley, Ryutaro Hirose, Justin R. Md Parekh

    Background.: Despite an increasing demand for liver transplantation in older patients, our understanding of posttransplant outcomes in older recipients is limited to basic recipient and graft survival. Using National Surgical Quality Improvement Program Transplant, we tracked early outcomes after liver transplantation for patients >65. Methods.: We conducted a retrospective analysis of patients in National Surgical Quality Improvement Program Transplant between March 1, 2017 and March 31, 2019. Recipients were followed for 1 y after transplant with follow-up at 30, 90, and 365 d. Data were prospectively gathered using standard definitions across all sites. Results.: One thousand seven hundred thirty-one adult liver transplants were enrolled; 387 (22.4%) were >65 y old. The majority of older recipients were transplanted for hepatocellular carcinoma. The older cohort had a lower lab Model for End-Stage Liver Disease and was less likely to be hospitalized at time of transplant. Overall, older recipients had higher rates of pneumonia but no difference in intensive care unit length of stay (LOS), total LOS, surgical site infection, or 30-d readmission. Subgroup analysis of patients with poor functional status revealed a significant difference in intensive care unit and total LOS. Pneumonia was even more common in older patients and had a significant impact on overall survival. Conclusions.: By targeting patients with hepatocellular carcinoma and lower Model for End-Stage Liver Diseases, transplant centers can achieve nearly equivalent outcomes in older recipients. However, older recipients with poor functional status require greater resources and are more likely to develop pneumonia. Pneumonia was strongly associated with posttransplant survival and represents an opportunity for improvement. By truly understanding the outcomes of elderly and frail recipients, transplant centers can improve outcomes for these higher-risk recipients.


  • Young donors with severe acute kidney injury offer an opportunity to expand the donor pool

    by Julia Torabi, Jay A. Graham, Krystina Choinski, Sumanth Suresh, Attasit Chokechanachaisakul, Maria Ajaimy, Layla Kamal, Enver Akalin, Milan Kinkhabwala, Stuart Greenstein, et al.


  • Open Access

    Comparing the Predictive Power of Preoperative Risk Assessment Tools to Best Predict Major Adverse Cardiac Events in Kidney Transplant Patients

    by Colin P. Dunn, Emmanuel U. Emeasoba, Ari J. Holtzman, Michael Hung, Joshua Kaminetsky, Omar Alani, Stuart M. Greenstein

    Background. Patients undergoing kidney transplantation have increased risk of adverse cardiovascular events due to histories of hypertension, end-stage renal disease, and dialysis. As such, they are especially in need of accurate preoperative risk assessment. Methods. We compared three different risk assessment models for their ability to predict major adverse cardiac events at 30 days and 1 year after transplant. These were the PORT model, the RCRI model, and the Gupta model. We used a method based on generalized U-statistics to determine statistically significant improvements in the area under the receiver operator curve (AUC), based on a common major adverse cardiac event (MACE) definition. For the top-performing model, we added new covariates into multivariable logistic regression in an attempt to create further improvement in the AUC. Results. The AUCs for MACE at 30 days and 1 year were 0.645 and 0.650 (PORT), 0.633 and 0.661 (RCRI), and finally 0.489 and 0.557 (Gupta), respectively. The PORT model performed significantly better than the Gupta model at 1 year (p=0.039). When the sensitivity was set to 95%, PORT had a significantly higher specificity of 0.227 compared to RCRI’s 0.071 (p=0.009) and Gupta’s 0.08 (p=0.017). Our additional covariates increased the receiver operator curve from 0.664 to 0.703, but this did not reach statistical significance (p=0.278). Conclusions. Of the three calculators, PORT performed best when the sensitivity was set at a clinically relevant level. This is likely due to the unique variables the PORT model uses, which are specific to transplant patients.


  • Open Access

    A Retrospective Cohort Study on Rehospitalization following Expanded Criteria Donor Kidney Transplantation

    by Colin Dunn, Emmanuel U. Emeasoba, Michael Hung, Ari Holtzman, Eran Bellin, Stuart Greenstein

    Background. Expanded criteria donor (ECD) kidneys are commonly used but are associated with increased graft failure. Graft failure is in turn related to rehospitalization within thirty days post transplant. Our goal was to determine whether ECD kidneys independently lead to rehospitalization within 30 days, 1 year, and 2 years after transplant.Methods. All adult first-time recipients of deceased donor kidneys transplanted from 2003–2012 at our center were reviewed. Models included demographics, medical comorbidities, center for disease control high-risk kidney, ECD kidney, ischemia times, cause of renal failure, immunosuppressive regimen, positive psychiatric screening, alcoholism, surgeon, year the transplant was performed, years on dialysis before transplant, and the number of inpatient hospitalizations within 6 months prior to transplant. We conducted Andersen–Gill modeling and propensity score matching followed by logistic regression. We also used multivariable linear regression to predict average length of stay during rehospitalization.Results. More ECD patients had a rehospitalization at 1 year (70.3% versus 59%, log-rank testp=0.014). Thirty-day and 2-year time marks were not significant. Andersen–Gill models predicting successive hospitalizations yielded HR of 1.42 (p=0.002) and 1.32 (p=0.015) for ECD patients at 1 and 2 years of after transplantation, respectively. Propensity score matching and logistic regression showed a significant relative risk of 1.630 at one year (p=0.033) and 1.313 at two years (p=0.268). There was no significant association between ECD and subsequent lengths of hospital stay.Conclusion. Receiving an ECD kidney is independently associated with multiple readmissions within 2 years of transplant but unrelated to length of stay.


  • Patients’ Expectations for Longevity of Kidney Transplant

    by Michelle Gruttadauria, Colin Dunn, Juan Lin, Joshua R. Kaminetsky, Kayla Applebaum, Daniella Portal, Omar Mohammed, Juan Rocca, Stuart Greenstein

    Introduction: Prior to transplantation, the transplant team is responsible for transplant education and posttransplant expectations. The majority of outcomes research focuses on 1- and 3-year graft survival, with a lack of literature focused upon whether patients have a realistic understanding of how many years deceased donor kidneys can be expected to function after transplant. Objective: To determine whether potential kidney transplant patients’ expectations for how long a deceased donor kidney will function after transplantation differs from transplant surgeons, using quantitative analysis. Design: A cross-sectional survey was used with potential adult kidney transplant recipients and transplant surgeons. Patient surveys included demographics, quality-of-life questions, and questions of expectations of kidney function for deceased donor kidneys from the Kidney Donor Profile Index. The survey categorized donor organ risk as 0% to 20%, 21% to 85%, and 86% to 100%, and results were compared to responses from US Transplant Surgeons. Surgeons were contacted via e-mail using an online survey program. Results: Responses included 154 transplant surgeons and 172 patients. Surgeon and patient responses were compared using Fisher exact test, showing a significant difference in each of the donor organ categories. We found that 47% of patient respondents did not correctly interpret the Kidney Donor Profile Index continuum. Conclusion: In every organ donor category, patients had a significantly different expectation for how long a transplanted kidney will last after transplant when compared to transplant surgeons. More study is required to determine why 47% of patients did not correctly interpret the Kidney Donor Profile continuum.